Caplin Point Laboratories informs about press release

16 Dec 2024 Evaluate
Caplin Point Laboratories has attached a Press Release regarding grant of final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Difluprednate Ophthalmic Emulsion, 0.05% (Eye drops), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) DUREZOL, from Sandoz Inc, to Subsidiary Caplin Steriles. 

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2396.80 -44.15 (-1.81%)
18-Dec-2024 14:03 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1801.25
Dr. Reddys Lab 1276.10
Cipla 1477.90
Lupin 2100.10
Zydus Lifesciences 982.35
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.